Using nanoscale particles to heal tissue damage
Therapeutic nanoscale matrimeres
This study is testing a new treatment using tiny particles to help heal damaged blood vessel cells, which could help people with issues like swelling and tissue problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11078798 on NIH RePORTER |
What this research studies
This research investigates a new type of nanoparticle, called matrimeres, which are designed to restore the function of endothelial cells that have been damaged due to tissue injury. The approach focuses on delivering specific matrix molecules that are crucial for cell signaling and maintaining the integrity of blood vessels. By utilizing naturally secreted nanoparticles from mesenchymal stromal cells, the research aims to activate endothelial cells and repair the leaky barriers that can lead to serious complications like edema and tissue fibrosis. Patients may benefit from this innovative treatment if it proves effective in restoring normal tissue function.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals suffering from conditions that lead to endothelial dysfunction or tissue injury, such as those with chronic inflammatory diseases or injuries.
Not a fit: Patients with stable endothelial function or those not experiencing tissue injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel therapeutic approach to treat various conditions associated with tissue injury and vascular dysfunction.
How similar studies have performed: While the concept of using nanoparticles for tissue repair is gaining traction, this specific approach with matrimeres is relatively novel and has not been extensively tested in clinical settings.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Shin, Jae-Won — University of Illinois at Chicago
- Study coordinator: Shin, Jae-Won
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.